13-102872397-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000123.4(ERCC5):c.2878G>T(p.Glu960*) variant causes a stop gained, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000123.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000123.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERCC5 | NM_000123.4 | MANE Select | c.2878G>T | p.Glu960* | stop_gained splice_region | Exon 13 of 15 | NP_000114.3 | ||
| BIVM-ERCC5 | NM_001204425.2 | c.4240G>T | p.Glu1414* | stop_gained splice_region | Exon 21 of 23 | NP_001191354.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ERCC5 | ENST00000652225.2 | MANE Select | c.2878G>T | p.Glu960* | stop_gained splice_region | Exon 13 of 15 | ENSP00000498881.2 | ||
| BIVM-ERCC5 | ENST00000639435.1 | TSL:5 | c.4240G>T | p.Glu1414* | stop_gained splice_region | Exon 23 of 25 | ENSP00000491742.1 | ||
| BIVM-ERCC5 | ENST00000639132.1 | TSL:5 | c.3553G>T | p.Glu1185* | stop_gained splice_region | Exon 22 of 24 | ENSP00000492684.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251332 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360 show subpopulations
ClinVar
Submissions by phenotype
Xeroderma pigmentosum Pathogenic:1
Variant summary: The ERCC5 c.2878G>T (p.Glu960X) variant results in a premature termination codon, predicted to cause a truncated or absent ERCC5 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. This variant was found in 1/120768 control chromosomes at a frequency of 0.0000083, which does not exceed the estimated maximal expected allele frequency of a pathogenic ERCC5 variant (0.0007071). A publication cites the variant in an affected compound heterozygote individual. A functional study, Nouspikel_1994, indicates that the variant is extremely UV sensitive at higher does. In addition, a reputable database classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.
Xeroderma pigmentosum, group G Pathogenic:1
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu960*) in the ERCC5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC5 are known to be pathogenic (PMID: 23370536, 24700531, 30919937). This variant is present in population databases (rs121434570, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with Xeroderma pigmentosum (PMID: 7951246). ClinVar contains an entry for this variant (Variation ID: 16566). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at